Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Virol ; 166(6): 1533-1545, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33683476

ABSTRACT

Beekeeping is a widespread activity in Argentina, mainly producing honey that has gained both national and international recognition. There are more than 3,000,000 hives in the country, mainly concentrated in Buenos Aires Province (approximately 1,000,000 hives). In recent decades, worrying rates of hive loss have been observed in many countries around the world. In Latin America, the estimated loss of hives is between 13% (Peru and Ecuador) and 53% (Chile). Argentina had annual losses of 34% for the period of October 1, 2016 to October 1, 2017. The causes of these losses are not clear but probably involve multiple stressors that can act simultaneously. One of the main causes of loss of bee colonies worldwide is infestation by the ectoparasitic mite Varroa destructor in combination with viral infections. To date, 10 viruses have been detected that affect honey bees (Apis mellifera) in Argentina. Of these, deformed wing virus, sacbrood virus, acute bee paralysis virus, chronic bee paralysis virus, and Israeli acute bee paralysis can be transmitted by mites. Deformed wing virus and the AIK complex are the viruses most often associated with loss of hives worldwide. Considering that bee viruses have been detected in Argentina in several hymenopteran and non-hymenopteran insects, these hosts could act as important natural reservoirs for viruses and play an important role in their dispersal in the environment. Further studies to investigate the different mechanisms by which viruses spread in the environment will enable us to develop various strategies for the control of infected colonies and the spread of viruses in the habitat where they are found.


Subject(s)
Bees/virology , Animals , Argentina , DNA Viruses/genetics , DNA Viruses/isolation & purification , Host-Pathogen Interactions , RNA Viruses/genetics , RNA Viruses/isolation & purification
2.
Equine Vet J ; 52(5): 760-764, 2020 Sep.
Article in English | MEDLINE | ID: mdl-31975477

ABSTRACT

BACKGROUND: In newborn foals the absorption of colostrum immunoglobulins in the small intestine is maximal up to 8 hours after birth and then progressively decreases to become null after 24 hours post-partum. Thus, equine practitioners need a simple, quick, inexpensive and reliable field test to identify foals affected by failure of passive transfer rather than an accurate method yielding quantitative results within the whole range of immunoglobulin concentrations. OBJECTIVE: As the validity of the immunocrit method to detect failure of passive transfer in foals had not been evaluated before, the objective of this study was to test the ability of this method to detect the concentration of immunoglobulins in a large number of foal serum samples. STUDY DESIGN: Assay validation using samples collected for clinical purposes. METHODS: The immunocrit test, using a 40% ammonium sulphate solution, was used to measure the concentration of immunoglobulins in serum samples from 211 newborn Thoroughbred foals. The results were compared, by statistical analysis, with those of agarose gel electrophoresis, a reference quantitative method. RESULTS: The values obtained by the immunocrit method were significantly correlated (R = .871; P < .001) with those measured by agarose gel electrophoresis. A cut-off value of 8 g/L of serum immunoglobulins by agarose gel electrophoresis and its equivalent of 9.5% for the immunocrit test was indicative of failure of passive transfer. The sensitivity and specificity of the immunocrit method at this cut-off point were 94% (95% CI, 90-97.3) and 82% (95% CI, 72.13-91.8) respectively. MAIN LIMITATIONS: Variable times of sample extraction after colostrum suckling, over the study period. CONCLUSIONS: The immunocrit test provides a quantitative, quick, inexpensive, reliable and objective method to detect failure of passive transfer of maternal immunity in newborn foals, which is easy to perform directly in horse farms, with minimum laboratory equipment.


Subject(s)
Immunity, Maternally-Acquired , Immunoglobulin G , Animals , Animals, Newborn , Colostrum , Female , Horses , Pregnancy , Sensitivity and Specificity
3.
Open Vet J ; 9(1): 33-37, 2019 04.
Article in English | MEDLINE | ID: mdl-31086763

ABSTRACT

Bovine leukemia virus (BLV) is the agent responsible for enzootic bovine leukosis, the most common neoplastic disease in cattle. The horn fly, a major hematophagous pest of cattle, is able to transmit different diseases in cattle. However, its implication in BLV transmission under a natural environment is still discussed. The objectives of this work were to determine the presence of BLV in horn flies (by sequencing) and to evaluate the ability of horn flies to transmit BLV to cattle (through an experimental assay under a natural environment). To demonstrate the presence of BLV in the flies, 40 horn flies were collected from a BLV-positive cow with a sweep net and 10 pools with four horn-fly mouthparts each were prepared. The presence of BLV was determined by nested polymerase chain reaction and sequencing. To demonstrate BLV transmission, other 40 flies were collected from the same BLV-positive cow with a sweep net. Eight homogenates containing five horn-fly mouthparts each were prepared and injected to eight cows of different breeds, and blood samples were collected every 21 days. Then, to evaluate the ability of horn flies to transmit BLV to grazing cattle under natural conditions, both infected and uninfected cattle from the experimental transmission assay were kept together in the same paddock with more than 200 horn flies per animal for 120 days. Blood samples were collected every 20 days and the number of flies was determined. The sequencing results confirmed the presence of the provirus in horn flies. The results also confirmed that BLV transmission is a possible event, at least experimentally. However, the role of horn flies as vectors of BLV under a natural grazing system is still discussed.


Subject(s)
Enzootic Bovine Leukosis/transmission , Insect Vectors/virology , Leukemia Virus, Bovine/isolation & purification , Muscidae/virology , Animals , Argentina , Cattle , Female , Insect Vectors/physiology , Muscidae/physiology , Polymerase Chain Reaction/veterinary , Proviruses/isolation & purification
4.
J Virol Methods ; 193(2): 519-20, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23886563

ABSTRACT

Enzootic Bovine Leukosis is a chronic disease caused by the bovine leukemia virus (BLV). Smudge cells, also known as Gumprecht shadows, are not simple artifacts of slide preparation, but ragged lymphoid cells found mainly in peripheral blood smears from human patients with chronic lymphocytic leukemia. In this study, we report the presence of Gumprecht shadows in peripheral blood from BLV-positive cattle.


Subject(s)
Enzootic Bovine Leukosis/pathology , Leukemia Virus, Bovine/isolation & purification , Leukocytes, Mononuclear/cytology , Animals , Cattle , Enzootic Bovine Leukosis/virology
5.
Protein Expr Purif ; 90(1): 1-8, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23631926

ABSTRACT

Suid Herpesvirus 1 (SHV-1) is the etiological agent of Aujeszky's disease (AD), which affects swine herds worldwide and causes substantial economic losses due to animal mortality and lost productivity. In order to eradicate SHV-1, vaccination programs using viruses lacking the gene encoding glycoprotein E (gE) are ongoing in several countries. These eradication programs have generated a currently unmet demand for affordable and sensitive tests that can detect SHV-1 infection, yet distinguish between infected and vaccinated pigs. To meet this demand, we used the baculovirus-insect cell system to produce immunologically authentic full-length recombinant gE protein for use in a serum ELISA assay. As previous efforts to clone the gE gene had failed due to its extremely high GC-content (75% average), we used betaine as a PCR enhancer to facilitate amplification of the entire gE gene from the Argentinian CL15 strain of SHV-1. The cloned gE gene was expressed at high levels in recombinant baculovirus-infected insect cells and reacted strongly with sera from SHV-1 infected pigs. We used the recombinant gE protein to develop a local indirect ELISA test with sensitivity and specificity comparable to currently available commercial tests. Thus, recombinant gE produced in baculovirus-infected insect cells is a viable source of antigen for the detection of SHV-1 in ELISA tests. We also provide evidence supporting a potential application of this recombinant form of gE as a SHV-1 subunit vaccine.


Subject(s)
Baculoviridae/genetics , Herpesvirus 1, Suid/isolation & purification , Pseudorabies/diagnosis , Viral Envelope Proteins/isolation & purification , Animals , Antibodies, Viral/blood , Enzyme-Linked Immunosorbent Assay , Male , Mice , Mice, Inbred BALB C , Pseudorabies/virology , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sensitivity and Specificity , Swine , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism
6.
Mol Biotechnol ; 54(2): 475-83, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22829115

ABSTRACT

Bovine leukemia is a common retroviral infection of cattle. The disease is characterized by a strong immunological response to several viral proteins, but the antibodies against p24 and gp51 are predominant. In this study, a recombinant baculovirus containing the gag gene p24 was constructed and the protein, used as antigen, analyzed by western blot and an indirect in-house rp24-ELISA test. This allowed detecting the presence of antibodies for bovine leukemia virus in a panel of cattle sera. The authentication of the protein expands its potential use for different medical applications, from improved diagnosis of the disease to source of antigens to be included in a subunit vaccine.


Subject(s)
Antigens, Viral/genetics , Enzootic Bovine Leukosis/genetics , Glycoproteins/genetics , Insecta/genetics , Leukemia Virus, Bovine/genetics , Viral Proteins/genetics , Animals , Antibodies, Viral/immunology , Antigens, Viral/immunology , Antigens, Viral/metabolism , Baculoviridae/genetics , Baculoviridae/metabolism , Cattle , Cell Line , Enzootic Bovine Leukosis/metabolism , Enzootic Bovine Leukosis/virology , Glycoproteins/immunology , Glycoproteins/metabolism , Insecta/metabolism , Insecta/virology , Leukemia Virus, Bovine/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Viral Proteins/immunology , Viral Proteins/metabolism
7.
Res Vet Sci ; 89(3): 460-4, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20434739

ABSTRACT

Bluetongue virus (BTV) is a double-stranded RNA virus that induces apoptosis both in mammalian cell cultures and in target tissues. Based on information that members of the mitogen-activated protein kinase family (MAPKs) are mediators of apoptosis, we have examined in detail the MAPK-dependent apoptosis in BTV infection. Previously, we have shown that apoptosis in BTV infection requires the participation of mitochondrial apoptotic pathways. In addition, we demonstrated that NF-κB is activated and that its inhibition substantially reduces cellular apoptosis. For the first time, here we demonstrated the activation of MAPKs after BTV infection. Moreover, by pre-treatment with MAPK inhibitors, c-Jun N-terminal kinases (JNKs) and p38 MAPK, but not extracellular signal-related kinase (ERK), significantly decreased the induction of apoptosis. JNK and p38 activation regulated the cytochrome c released from mitochondria and caspase 3 activation. These results strengthen the understanding of BTV infection and contribute to our previous data confirming that BTV infection induces robust apoptosis in mammalian cells and is likely to play a primary role in BTV pathophysiology.


Subject(s)
Apoptosis/physiology , Bluetongue/enzymology , MAP Kinase Signaling System/physiology , Animals , Blotting, Western/veterinary , Bluetongue/metabolism , Butadienes/pharmacology , Caspase 3/metabolism , Caspase 3/physiology , Cells, Cultured , Cytochromes c/metabolism , Cytochromes c/physiology , Enzyme Activation/physiology , Extracellular Signal-Regulated MAP Kinases/metabolism , Extracellular Signal-Regulated MAP Kinases/physiology , HeLa Cells , Humans , JNK Mitogen-Activated Protein Kinases/metabolism , JNK Mitogen-Activated Protein Kinases/physiology , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , Nitriles/pharmacology , Sheep , p38 Mitogen-Activated Protein Kinases/metabolism , p38 Mitogen-Activated Protein Kinases/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...